Market Access USA at eyeforpharma Philadelphia
April 15 - 16, 2020 - Philadelphia PA USeyeforpharma by Reuters Events
ksharp@eyeforpharma.com
Phone:0000000000
Unite around a sustainable value model for innovation Access is now everybody's business. From clinical through commercial, executives must adjust their strategy to the rapidly changing access environment in the USA. We need company-wide appreciation of how RWE can determine better value propositions, we must all align to shifting customer desires to focus on early detection and prevention, and we must consider ourselves in alignment or even partnership with payers. Most importantly, everyone must align to the simple premise that the only way medicines improve lives is if patients can actually access them. For that reason, our agenda contains influencers from a broader group than ever before: patient groups, providers, academia, pharma and industry bodies, we have sourced the ingredients for a revolution in access that delivers a roadmap for sustainable innovation. 4 Essential themes: Ensure patients can access innovation: Hear ICER, MITDIGGs and the National Pharmaceutical Council unpack realistic strategies for a sustainable value model Demonstrate value through evidence: Help your customers distinguish the value of RWE and create the infrastructure Partner with providers: Reframe your priorities through our executive-led IDN panel where they will be setting key priorities where customers want to get to work with you tonight Level up your value strategy with AI: Use outcomes data to create personalized value propositions for providers and discover new working areas to improve quality of care